Top Healthcare Technology Stocks For 2016: Hanwha SolarOne Co. Ltd.(HSOL)
Hanwha Solarone Co., Ltd., an investment holding company, engages in the manufacture and sale of silicon ingots, silicon wafers, and PV cells and modules. The company also offers mono crystalline and multi crystalline silicon cells; and provides PV module processing services. It sells its products to solar power system integrators and distributors primarily in Germany, Italy, Australia, the United States, the Czech Republic, Spain, and China. The company was formerly known as Solarfun Power Holdings Co., Ltd. and changed its name to Hanwha SolarOne Co., Ltd. in December 2010. Hanwha Solarone Co., Ltd. was founded in 2004 and is based in Qidong, the People?s Republic of China.
Advisors' Opinion:- [By Paul Ausick]
Big Earnings Movers: Hanwha SolarOne Co. (NASDAQ: HSOL) is down 13.9% at $4.36. D.R. Horton Inc. (NYSE: DHI) is up 4.7% at $18.91 on good earnings boosted by land sales.
- [By Travis Hoium]
What: Solar stocks are shooting higher again today as the strong run in 2013 continues. LDK Solar (NYSE: LDK ) , Canadian Solar (NASDAQ: CSIQ ) , Yingli Green Energy (NYSE: YGE ) , Hanwha SolarOne (NASDAQ: HSOL ) , and JinkoSolar (NYSE: JKS ) led the way, gaining between 10% and 22% today.
- [By Sean Williams]
Lights out, China
China may have its fair share of struggles -- which has caused its strong economy to back off its 30-year average growth rate of 10% -- but when push comes to shove, plenty of investors are still paying close attention to multinational companies making investments in China. However, if there were one sector with a gigantic "beware" stamp attached to it, it would be Chinese solar panel producers like Hanwha SolarOne (NASDAQ: HSOL ) . - [By Travis Hoium]
News and notes
Hanwha SolarOne (NASDAQ: HSOL ) announced! another $100 million in financing this week, this time a term loan from the Export-Import Bank of Korea.
source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-healthcare-technology-stocks-for-2016.html
No comments:
Post a Comment